Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 7/20 | 0.63 |
| ▸ | ACE | P12821 | 6/20 | 0.63 |
| ▸ | CPA1 | P15085 | 2/20 | 0.63 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.63 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.57 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.53 |
| ▸ | CTSL | P07711 | 1/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.52 |
| ▸ | CTSS | P25774 | 1/20 | 0.52 |
| ▸ | FCER2 | P06734 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4739434 | 1.00 | MME (0.63) | MMEACECPA1ACE2ITGB3 | |
| SCHEMBL4740393 | 1.00 | MME (0.63) | MMEACECPA1ACE2ITGB3 | |
| SCHEMBL30491086 | 1.00 | MME (0.63) | MMEACECPA1ACE2ITGB3 | |
| SCHEMBL30491089 | 1.00 | MME (0.63) | MMEACECPA1ACE2ITGB3 | |
| SCHEMBL22764712 | 0.95 | MME (0.64) | MMEACECPA1ACE2ITGB3 | |
| SCHEMBL25410999 | 0.95 | MME (0.65) | MMEACECPA1ACE2ITGB3 | |
| SCHEMBL30516543 | 0.95 | MME (0.65) | MMEACECPA1ACE2ITGB3 | |
| SCHEMBL25413002 | 0.95 | MME (0.65) | MMEACECPA1ACE2ITGB3 | |
| SCHEMBL25410995 | 0.95 | MME (0.65) | MMEACECPA1ACE2ITGB3 | |
| Dl-Phenylalanine SCHEMBL25412486 | 0.92 | MME (0.56) | MMEACECPA1ACE2ITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116565119-A | Positive electrode sheet, secondary battery, method of manufacturing the same, and device including the secondary battery | 宁德时代新能源科技股份有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-116565119-A | Positive electrode sheet, secondary battery, method of manufacturing the same, and device including the secondary battery | 宁德时代新能源科技股份有限公司 | 2023-08-08 | — | — | CN | disclosed |
| US-10308682-B2 | Inhibition of tumor growth with aggregates of small molecules | BRANDEIS UNIVERSITY (US) | 2019-06-04 | — | — | US | disclosed |
| US-20160016994-A1 | INHIBITION OF TUMOR GROWTH WITH AGGREGATES OF SMALL MOLECULES | BRANDEIS UNIVERSITY | 2016-01-21 | — | — | US | disclosed |
| WO-2014138367-A1 | INHIBITION OF TUMOR GROWTH WITH AGGREGATES OF SMALL MOLECULES | BRANDEIS UNIVERSITY (US) | 2014-09-12 | — | — | WO | disclosed |
| WO-2014120886-A1 | PLATELET ADDITIVE SOLUTION HAVING A SELF-ASSEMBLING HYDROGEL-FORMING PEPTIDE | VELICO MEDICAL, INC. (US) | 2014-08-07 | — | — | WO | disclosed |
| WO-2008085691-A2 | MULTIFUNCTIONAL SUPRAMOLECULAR HYDROGELS AS BIOMATERIALS | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2008-07-17 | — | — | WO | disclosed |
| US-20070224273-A1 | Multifunctional Supramolecular Hydrogels as Biomaterials | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (HK) | 2007-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160016994-A1 | INHIBITION OF TUMOR GROWTH WITH AGGREGATES OF SMALL MOLECULES | MAP2, TUBB1, TUBB | MME 2870/4885ACE 4271/4885CPA1 4609/4885 |
| US-10308682-B2 | Inhibition of tumor growth with aggregates of small molecules | MAP2, TUBB1, TUBB | MME 2870/4885ACE 4271/4885CPA1 4609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.